Researchers have developed a new tool for addressing disseminated intravascular coagulation (DIC) - a blood disorder that proves fatal in many patients..
Designed to provide optimal conditions whilst preventing contamination, the new CO
2 incubator with 180°C dry heat sterilisation has been developed by Haier Biomedical with users in mind.
Haier Biomedical, a leading global life-science equipment and cold-chain manufacturer, continues to grow and expand its product portfolio with the introduction of a new range of CO
2 incubators intended for tissue culture and cell biology applications.
This CO
2 incubator product line has been developed to address typical customer requirements such as precise temperature, humidity and CO
2 management and control, ease of cleaning, contamination prevention, simplicity of use and flexibility in terms of configuration. Watch this video to find out more Watch video
Entheon Biomedical Corp.: Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development
Entheon or the
Company ), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce the appointment of Dr. Brian Jahns to the role of Chief Business Officer.
Dr. Jahns brings more than 20 years of business leadership and biopharmaceutical expertise to his role in overseeing the overall business development of Entheon, including the development and maintenance of strategic relationships with third parties, including regulatory authorities. Importantly, Dr. Jahns will also work to develop a commercialization and post-market strategy for Entheon s therapeutic protocols, while developing and advancing other related products, services, and initiatives of the company.
Biomedical engineer leads team at Case Western Reserve, Cleveland VA in developing blood test to determine whether patient could get potentially deadly.
Covid update: 11 February 2021
11 Feb 2021
A round up of this week s coronavirus-related news and countermeasures from the photonics industry.
The robot coughs out a precise, repeatable cloud of droplets and aerosols. Research into the spread of coronavirus has been joined by a robot that, unlike a person, can cough out a precisely specified and repeatable consistency of droplets and aerosols. The coughing robot helps determine the effect of masks and various air purifiers on the spread of droplets and aerosols. Measurements made with the robot are also used to verify the accuracy of computer simulations.
Since autumn 2020, a joint project by Finland-based research agency VTT, Tampere University and THL (the Finnish Institute for Health & Welfare) has studied the mechanisms of the droplet and aerosol transmission of Covid-19 and the methods for reducing the risk of transmission.